{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:00:31Z","timestamp":1793066431217,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T00:00:00Z","timestamp":1405296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jhep.2014.07.012","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T01:15:15Z","timestamp":1414977315000},"page":"S58-S68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":747,"special_numbering":"S","title":["Natural history of hepatitis C"],"prefix":"10.1016","volume":"61","author":[{"given":"Rachel H.","family":"Westbrook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Dusheiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.07.012_b0005","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2014.07.012_b0015","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"van de Laar","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.012_b0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0025","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/gast.1997.v113.pm9352872","article-title":"Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection","volume":"113","author":"Alric","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.07.012_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0035","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.07.012_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.07.012_b0045","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.07.012_b0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2893.2007.00873.x","article-title":"Spontaneous clearance of childhood hepatitis C virus infection","volume":"14","author":"Yeung","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2014.07.012_b0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ajg.2013.427","article-title":"Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study","volume":"109","author":"Kamal","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2014.07.012_b0065","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0070","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/hep.26782","article-title":"An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients","volume":"59","author":"Kokordelis","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0075","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.42.4.570","article-title":"Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection","volume":"42","author":"Haydon","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.07.012_b0080","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1053\/j.gastro.2009.10.056","article-title":"Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection","volume":"138","author":"McMahon","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.07.012_b0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cit799","article-title":"Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men","volume":"58","author":"Fierer","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2014.07.012_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/apc.2013.0130","article-title":"The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic","volume":"28","author":"Taylor","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jhep.2014.07.012_b0095","article-title":"Next generation sequencing sheds light on the natural history of hepatitis C infection in patients that fail treatment","author":"Abdelrahman","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0100","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2010.08.029","article-title":"Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility","volume":"54","author":"Martin","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/apc.2013.0254","article-title":"Tasks and strategies of self-management of living with antiretroviral therapy in Uganda","volume":"27","author":"Martin","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jhep.2014.07.012_b0110","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199506013322202","article-title":"Clinical outcomes after transfusion-associated hepatitis C","volume":"332","author":"Tong","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jhep.2000.8169","article-title":"Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study","volume":"32","author":"Wiese","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0120","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.510230607","article-title":"The long-term pathological evolution of chronic hepatitis C","volume":"23","author":"Yano","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510230406","article-title":"The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses","volume":"23","author":"Kobayashi","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0130","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.07.012_b0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jmv.10448","article-title":"Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study","volume":"71","author":"Watanabe","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2014.07.012_b0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-140-5-200403020-00033","article-title":"Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?","volume":"140","author":"Zeuzem","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/gut.44.4.563","article-title":"The natural course of hepatitis C virus infection 18years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre","volume":"44","author":"Datz","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.07.012_b0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2893.2003.00484.x","article-title":"Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection","volume":"11","author":"Yi","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2000-9258","article-title":"Fibrosis in patients with chronic hepatitis C: detection and significance","volume":"20","author":"Poynard","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.07.012_b0170","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"Poynard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.07.012_b0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2893.2002.00340.x","article-title":"Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model","volume":"9","author":"Deuffic-Burban","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.52.2.288","article-title":"Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies","volume":"52","author":"Castera","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.07.012_b0185","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0190","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.012_b0195","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2893.2009.01133.x","article-title":"Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection","volume":"16","author":"Martin-Carbonero","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0200","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/gutjnl-2013-305115","article-title":"Treatment of patients with dual hepatitis B and C: a step in the right direction","volume":"63","author":"Aghemo","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.07.012_b0205","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.25321","article-title":"Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis","volume":"128","author":"Cho","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2014.07.012_b0210","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/cncr.21702","article-title":"Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients","volume":"106","author":"Squadrito","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2014.07.012_b0215","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-127-10-199711150-00003","article-title":"Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy","volume":"127","author":"Marcellin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0220","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0225","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.07.012_b0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2893.2003.00403.x","article-title":"Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon","volume":"10","author":"Toccaceli","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0235","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.07.012_b0240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0245","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0250","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1053\/j.gastro.2010.02.058","article-title":"Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C","volume":"138","author":"Fontana","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.07.012_b0255","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0260","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegnu","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.07.012_b0265","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ajg.2010.456","article-title":"Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C","volume":"106","author":"Fontana","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.07.012_b0270","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1572-0241.2006.00743.x","article-title":"Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis","volume":"101","author":"Rincon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.07.012_b0275","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/hep.23528","article-title":"Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study","volume":"51","author":"Bruno","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0280","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/j.1572-0241.2003.07678.x","article-title":"The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?","volume":"98","author":"Goodgame","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.07.012_b0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2005.10.002","article-title":"Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study","volume":"44","author":"El-Serag","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0290","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2893.2005.00707.x","article-title":"Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis","volume":"13","author":"Hung","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0295","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.510290439","article-title":"Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis","volume":"29","author":"Ikeda","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0305","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2893.2001.00271.x","article-title":"Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update","volume":"8","author":"Thevenot","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0315","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/cid\/cit234","article-title":"A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis","volume":"57","author":"Aleman","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2014.07.012_b0320","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/jac\/dks269","article-title":"A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy","volume":"67","author":"Chang","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhep.2014.07.012_b0325","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.20793","article-title":"Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy","volume":"42","author":"Everson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0330","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.07.012_b0335","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/jhep.2002.31773","article-title":"Hepatitis C virus kinetics during and immediately after liver transplantation","volume":"35","author":"Garcia-Retortillo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0340","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/lt.21117","article-title":"A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation","volume":"13","author":"Yilmaz","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.012_b0345","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-200201150-00010","article-title":"Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft","volume":"73","author":"Sanchez-Fueyo","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2014.07.012_b0350","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.07.012_b0355","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2004.06.029","article-title":"Fibrosis progression after liver transplantation in patients with recurrent hepatitis C","volume":"41","author":"Neumann","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0360","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/lt.22175","article-title":"Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria","volume":"16","author":"Narang","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.012_b0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2014.07.012_b0370","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0375","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2011.06.031","article-title":"Immunosuppression and HCV recurrence after liver transplantation","volume":"56","author":"Samonakis","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0380","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.12668","article-title":"Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients","volume":"14","author":"Terrault","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2014.07.012_b0385","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.20995","article-title":"Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation","volume":"13","author":"Terrault","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.012_b0390","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20189","article-title":"Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation","volume":"10","author":"Stravitz","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.012_b0395","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2013.08.003","article-title":"Chronic HCV infection is a risk factor of ischemic stroke","volume":"231","author":"Adinolfi","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2014.07.012_b0400","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0405","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0410","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0415","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004836-199712000-00013","article-title":"Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha","volume":"25","author":"Akriviadis","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2014.07.012_b0420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0000000000000005","article-title":"HIV\/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma","volume":"28","author":"Merchante","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.012_b0425","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2008.11.018","article-title":"Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study","volume":"50","author":"Salmon-Ceron","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.012_b0430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.25800","article-title":"The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection","volume":"57","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0435","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2893.2009.01154.x","article-title":"Quality of life considerations for patients with chronic hepatitis C","volume":"16","author":"Foster","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0440","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2893.2010.01361.x","article-title":"Tobacco and other factors have a negative impact on quality of life in hepatitis C patients","volume":"18","author":"Yamini","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.07.012_b0445","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1023\/A:1018852309885","article-title":"Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life","volume":"42","author":"Hunt","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2014.07.012_b0450","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510290124","article-title":"Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group","volume":"29","author":"Bonkovsky","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0455","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.24656","article-title":"Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations","volume":"55","author":"Martin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.012_b0460","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2014.01.020","article-title":"Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model","volume":"60","author":"Innes","year":"2014","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T19:12:47Z","timestamp":1565982767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814004814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0168827814004814"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.07.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}